DC Chemicals · Product datasheet

Obicetrapib (AMG-899,TA-8995) · DC10134

Obicetrapib, also known as TA-8995, is a CETP inhibitor for lipoprotein metabolism and cholesterol-efflux research.

ParameterValue
Chemical Name4-((2-((3,5-bis(trifluoromethyl)benzyl)((2R,4S)-1-(ethoxycarbonyl)-2-ethyl-6-
CAS No.866399-87-3
SynonymsAMG 899,TA 8995,AMG899,TA8995,
FormulaC32H31F9N4O5
M.Wt722.6
SMILESO=C(O)CCCOC1=CN=C(N(CC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)[C@H]3C[C@@H](CC)N(C(OCC)=O)C4=C3C=C(C(F)(F)F)C=C4)N=C1
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity summary

Obicetrapib, also known as TA-8995, is a CETP inhibitor for lipoprotein metabolism and cholesterol-efflux research.

View referenced In Vitro and In Vivo results on the product page

References

  1. van Capelleveen JC, et al. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses. Journal of clinical lipidology (2016).

Available packs

  • 1g · US$2,600
  • 100mg · US$750
  • 250mg · US$1,200
View product and biological activity →

Cart

Request quotation